Intercept Pharmaceuticals Inc. Moves Forward With OCA REGENERATE Trial
May 20, 2015 at 12:11 PM EDT
On May 19, Intercept Pharmaceuticals Inc. announced plans for an international Phase 3 trial of OCA in patients with NASH.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|